Please login to the form below
Chiesi's Holoclar wins UK Prix Galien orphan drug award
Novartis and Astellas also scoop prizes at the prestigious ceremony
UK pharma apprenticeships doubled in 2015
Stronger industry-academia revealed in new ABPI report
Virgo Health launches healthcare innovation hub
The Egg service specialises in creating
holistic solutions for patients and HCPs
Consilium Strategic Communications wins Vectura account
Will advise on financial and corporate PR
following SkyePharma merger
Novartis seeks first-line use for lung cancer drug Zykadia
Looks to go
head-to-head with Pfizer/Merck KGaA’s Xalkori and Roche’s Alecensa
The Prostate Project kicks of 2016 OctoBeardFest campaign
Aims to raise awareness and funds for
prostate cancer research
Lundbeck trial failure dashes hopes in Alzheimer's once again
Phase III trial fails to substantially improve cognition despite promising phase II data
Gilead's ulcerative colitis antibody flunks trial
Halts trial
early as preliminary data shows no evidence of efficacy
AZ withdraws EU filing for ovarian cancer drug cediranib
Maintains
cediranib’s value as a combination therapy despite EMA information request
Surviving Brexit
How UK biopharma must adapt to a changing landscape
-
Key AccountsBut not as we know it?
-
The UK's new Cancer Drugs Fund"Clearer, faster decision-making" promised
-
BMS chases after Roche in EU bladder cancer raceOpdivo set to go head-to-head with Tecentriq
-
Allergan buys two NASH drug developers in one dayMore than $1.7bn paid for Tobira Therapeutics and Akarna Therapeutics
-
ROAD Comms wins antimicrobial resistance accountSelected by GAMA Healthcare to create infection control campaign
-
Medical Research Council launches disease compounds research libraryTeams up with AZ, GSK, Janssen, Pfizer, Takeda and UCB
-
GSK names Emma Walmsley as next CEOFirm's consumer healthcare head will succeed Sir Andrew Witty in March 2017
-
Sarepta soars as FDA clears its muscular dystrophy drugAnalysts anticipate blockbuster status for DMD therapy despite efficacy concerns
-
Sanofi fires off another lawsuit against a Lantus biosimilarAlleges patent infringement by Merck & Co’s biosimilar version filed in the US last month
Latest appointments
-
EMD Serono appoints neurology and immunology SVPPromotes head of US Fertility and Endocrinology Craig Millian
-
XenoGesis appoints business development consultantSabrina Mogle will spearhead CRO’s US growth
-
Bedrock appoints new commercial directorDr Laura Ciccolini brings experience from the Biopharm Group and Sigma Aldrich
-
emotive adds to medical writing and client services teamsIan Seymour and Aki Okazaki join the agency
-
EMA’s head of international affairs steps downEmer Cooke will take up new post at the WHO in November
Featured jobs
- Junior - Mid Level Medical Copywriter, Healthcare Advertising Ag...
-
£30-35,000 according to skills and experience
- Principal Medical Writer
-
Great salary and benefits
ID Search & Selection
- Healthcare Advertising Scientific Copywriter
-
Salary TBC
- Director, Scientific Services
-
£80 – 100,000 or more according to skills and experience + benefits
Media Contacts (Recruitment Consu ...
- Account Director - Medical Communications
-
Great salary and benefits
- Senior Medical Writer – Med Comms – Herts
-
Salary TBC
- Director, Scientific Services
-
Great salary and benefits
ID Search & Selection
- Senior Account Director, Healthcare Advertising
-
£65,000 - £75,000 according to skills and experience
- Principal Medical Writer
-
£48 - 58,000 according to skills and experience + benefits
Media Contacts (Recruitment Consu ...
- Account Director – Healthcare Advertising
-
Salary TBC
- HONG KONG!!! Senior Medical Writer & Principal Medical Write...
-
HIGHLEY COMPETATIVE SALARY, BONUS & BENEFITS
- Brand Manager - Rare Diseases - Brand Champion - South East
-
Highly Competitive Salary, Bonus & Benefits
Subscribe to our email news alerts
- Chiesi's Holoclar wins UK Prix Galien orphan drug award
- Virgo Health launches healthcare innovation hub
- Consilium Strategic Communications wins Vectura account
- Novartis seeks first-line use for lung cancer drug Zykadia
- The Prostate Project kicks of 2016 OctoBeardFest campaign
- Lundbeck trial failure dashes hopes in Alzheimer's once again
PMHub
CMR
Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...
Latest intelligence
- Market access improvements in Turkey
- ...
- Showcasing our multichannel capabilities in Berlin
- Join Anthill for conferences in October to understand how to bring value to HCPs through multichannel communications...
- What is MaxDiff?
- MaxDiff - (aka maximum difference scaling) can help market researchers pare down a wealth of information into precise and actionable insights. Sarah Mackinnon, Research Manager at Creative Medical Research, looks...
Quick links
Infographics
